Perceptive Advisors
109 portfolio companies · 13 on the map · $4.4B raised · 12 cities
Portfolio map
13 Perceptive Advisors portfolio companies on the map.
Portfolio companies

Ocular Therapeutix
Bedford
Ocular Therapeutix develops and commercializes ophthalmic therapeutic products by using hydrogel technology.
Pharmaceutical Manufacturing$1.2BEst. 2006
Zentalis
San Diego
Zentalis is a pharmaceutical company focused on developing clinical therapeutics for cancer patients.
Biotechnology Research$896.6M
Amylyx Pharmaceuticals
Cambridge
Amylyx Pharmaceuticals specializes in providing solutions for Alzheimer’s and other diseases of the brain.
Pharmaceutical Manufacturing$623.5M
Synthego
Menlo Park
Synthego is a genome engineering company that enables access to CRISPR to accelerate life science research and development.
Biotechnology Research$459.7MEst. 2012
Absci
Vancouver
Absci is the drug & target discovery company harnessing deep learning AI & synthetic biology to expand the therapeutic potential of proteins
Biotechnology Research$394.3MEst. 2011
Stoke Therapeutics
Bedford
Stoke is developing antisense oligonucleotide medicines that target RNA splicing to increase gene expression for treatment.
Biotechnology Research$360.1MEst. 2017
Anteris Technologies
Eagan
Anteris Technologies is a structural heart company focused on developing innovative & durable health solutions.
Medical Equipment Manufacturing$354.3MEst. 2006Hiring fast- TB
TORL BioTherapeutics
Culver City
TORL BioTherapeutics is a clinical-stage biopharmaceutical business.
Biotechnology Research$96MEst. 2018 
Bridge to Life
Northbrook
Bridge to Life is a supplier of preservation solutions globally with a focus on innovation in organ preservation and machine perfusion.
Biotechnology Research$57.5MEst. 2005M3 Biotechnology
Seattle
Athira Pharma is a clinical stage drug development company that specializes in biotechnology and pharmaceutical.
ResearchPublicEst. 2011
SpringWorks Therapeutics
Stamford
SpringWorks Therapeutics is a biopharmaceutical company that develops medicines for patients with severe rare diseases and cancer.
Biotechnology ResearchPublicEst. 2017- P
PanTheryx
Phoenix
PanTheryx is a nutrition and biotechnology company that utilizes the cellular and biomolecular processes of bovine colostrum.
Biotechnology ResearchEst. 2007 
REGENXBIO
Rockville
REGENXBIO develops adeno-associated viral vector-based therapeutics and research tools, offering NAV, a recombinant AAV-vector.
Biotechnology ResearchPublicEst. 2008
More portfolio companies
93 more Perceptive Advisors investments we track beyond the map — 109 tracked in total.
HonorConcord · Debt Financing
TalkiatryNew York · Series D
Caris Life SciencesIrving · Private Equity
Apogee TherapeuticsSan Francisco · Series B
Orchestra BioMedNew Hope · Series D
SOPHiA GENETICSBoston · Post-IPO Debt
Nautilus BiotechnologySan Carlos · Post-IPO Equity
Omada HealthSan Francisco · Series E
Nuvation BioNew York · Post-IPO Equity
KardiganSouth San Francisco · Series A
Forge BiologicsGrove City · Series B
Zevra TherapeuticsOrlando · Post-IPO Debt
PROCEPT BioRoboticsRedwood Shores · Series G
GeneDxStamford · Post-IPO Equity
Crossover HealthSan Clemente · Series D
Singular GenomicsLa Jolla · Series B
Genome MedicalSouth San Francisco · Series C
KindbodyNew York · Debt Financing
Capstan TherapeuticsSan Diego · Series B
Rapport TherapeuticsBoston · Series B
RayzeBioSan Diego · Series C
EmulateBoston · Series E
Crinetics PharmaceuticalsSan Diego · Post-IPO Equity
SomaLogicBoulder · Post-IPO Equity
CARGO TherapeuticsSan Mateo · Post-IPO Equity
DNAnexusMountain View · Series H
CareDxBrisbane · Post-IPO Debt
InSightecTirat Carmel · Private Equity
Affinia TherapeuticsWaltham · Series C
BridgeBioPalo Alto · Series D
Vyome TherapeuticsDelhi · Series D
CinCor PharmaCincinnati · Series B
Trinity BiotechBray · Post-IPO Debt
SaamaCampbell · Venture
A-Alpha BioSeattle · Series A
Impulse DynamicsMarlton · Venture
Avidity BiosciencesSan Diego · Series C
Establishment LabsNew York · Debt Financing
CueSan Diego · Private Equity
Edgewise TherapeuticsBoulder · Post-IPO Equity
Marea TherapeuticsSan Francisco · Series B
Soleno TherapeuticsRedwood City · Post-IPO Equity
MeiraGTxNew York · Post-IPO Equity
Outset MedicalSan Jose · Post-IPO Debt
Beam TherapeuticsCambridge · Post-IPO Equity
Sionna TherapeuticsNatick · Series C
Surf BioPalo Alto · Seed
Avita MedicalValencia · Post-IPO Debt
IsoPlexisBranford · Series D
AavantiBioCambridge · Series A
Pheon TherapeuticsLondon · Series B
OrpyxCalgary · Venture
ArcherDXBoulder · Series C
YarrowNew York · Venture
Allogene TherapeuticsSouth San Francisco · Convertible Note
Apyx MedicalClearwater · Post-IPO Debt
C4 TherapeuticsCambridge · Debt Financing
ADMA BiologicsRamsey · Debt Financing
AVEO OncologyCambridge · Post-IPO Equity
Cerebral TherapeuticsAurora · Series C
Nurix TherapeuticsSan Francisco · Post-IPO Equity
ExagenVista · Post-IPO Debt
Lyra TherapeuticsWatertown · Post-IPO Equity
Rain OncologyNewark · Series B
NeuroneticsMalvern · Post-IPO Debt
Bicycle TherapeuticsCambridge · Post-IPO Equity
VivoSenseNewport Coast · Series A
Clover HealthNashville · Post-IPO Equity
LianBioShanghai · Series A
Black Diamond TherapeuticsCambridge · Series C
Akero TherapeuticsCambridge · Post-IPO Equity
RenoviaBoston · Series C
ZymergenEmeryville · Series D
Poseida TherapeuticsSan Diego · Series C
Fusion PharmaceuticalsHamilton · Post-IPO Equity
Corbus PharmaceuticalsNorwood · Post-IPO Equity
TELA BioMalvern · Post-IPO Debt
scPharmaceuticalsLexington · Post-IPO Debt
Molecular TemplatesAustin · Post-IPO Debt
Point BiopharmaIndianapolis · Post-IPO Equity
AffimedHeidelberg · Debt Financing
VapothermExeter · Series D
CounsylSouth San Francisco · Venture
Eidos TherapeuticsPalo Alto · Series B
Bellicum PharmaceuticalsHouston · Series C
Clearside BiomedicalAlpharetta · Series C
AthenexBuffalo · Post-IPO Equity
Spectrum PharmaceuticalsHenderson · Post-IPO Equity
Atea PharmaceuticalsBoston · Series D
Neptune Wellness SolutionsQuebec · Post-IPO Equity
Motus GITirat Carmel · Venture
Arno TherapeuticsParsippany · Post-IPO Equity
Alliqua BioMedicalYardley · Post-IPO Debt
Portfolio map
13 Perceptive Advisors portfolio companies on the map.